Anti-KMT3D antibodies enable researchers to detect and measure the KMT3D antigen in biological samples. This target is a reported synonym of the SMYD1 gene, which encodes SET and MYND domain containing 1. This protein is known to function in chromatin remodeling and cardiac tissue development, among other biological roles. The human version of KMT3D has a canonical amino acid length of 490 residues and a protein mass of 56.6 kilodaltons. It is reported to be localized in the nucleus and cytoplasm of cells and notably expressed in the heart muscle and skeletal muscle. KMT3D is a member of the Class V-like SAM-binding methyltransferase protein superfamily. Indicated applications for KMT3D antibodies listed below include ELISA, Flow Cytometry, Western Blot, Immunofluorescence, and Immunohistochemistry.